Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

generative ai in education

Experts highlight 'significant gaps' in interventional radiology education

New survey results highlight medical students’ awareness, or lack thereof, of interventional procedures available to women.

icometrix MRI brain alzheimer's

American College of Radiology partners with AI developer, seeking to improve Alzheimer’s diagnoses

ACR is teaming with Belgium-based Icometrix, which is providing its brain MRI software to facilities participating in the Alzheimer’s Network for Treatment and Diagnostics. 

Sebastian Junger speaking at SIR 2025

Renowned journalist credits interventional radiology team for saving his life

Sebastian Junger says he hopes his story will help raise awareness of the many possibilities of interventional radiology.

SIR's new president, Robert Lookstein, MD, FSIR

Society of Interventional Radiology formally welcomes new president

Robert Lookstein, MD, FSIR, has been serving as the chief of interventional radiology at Mount Sinai for more than a decade and has worked in numerous roles with SIR for 20 years.

Lantheus

Lantheus completes acquisition of radiopharma firm Evergreen Theragnostics for up to $1B

Founded in 2019 and headquartered in Springfield, New Jersey, Evergreen develops and manufactures imaging agents for diagnosing and treating cancer. 

GE Healthcare and Nihon Medi-Physics

GE HealthCare finalizes purchase of radiopharma firm that generates $183M in revenue

The Chicago-based manufacturer is buying the remaining stake in Nihon Medi-Physics, a Japanese developer of imaging agents used in SPECT and PET exams. 

Thumbnail

Society of Interventional Radiology Foundation seeks to bolster research funding for the specialty

During their annual meeting being held this week in Nashville, the society announced the launch of the SIR Foundation Endowment. 

Interval breast cancer rates on the rise.

Rising rates of interval breast cancers have experts calling for more risk-based screenings

A new analysis suggests interval cancer rates among women with a prior history of breast cancer may be as high as 30%.